Volatile diagnostic techniques for ventilator associated pneumonia
Abstract
Ventilator associated pneumonia (VAP) is a significant challenge for the Intensive Care doctors worldwide. It is both difficult to diagnose accurately and quickly and to treat effectively once the diagnosis has been established. Current diagnostic microbiological methods of diagnosis can take up to 48 hours to yield results. Early diagnosis and treatment remain the best way of improving outcome for patients with VAP. In this study we look at novel diagnostic techniques for VAP. Electronic nose (Enose) technology was used to identify to identify the presence of microorganisms in bronchoalveolar lavage (BAL) fluid samples taken from the respiratory tracts of ventilated patients. The results were compared with standard microbiological culture and sensitivities. The Enose was able to discriminate 83% of samples into growth or no growth groups on samples grown in the lab. When the technique was employed to samples taken directly from patients the accuracy fell to 68.2%. This suggests that patient related factors may be reducing the accuracy of the Enose classification. The use of antimicrobial drugs prior to patient sampling is likely to have played a major role. The second part of this study used Gas Chromatography-Mass Spectrometry (GC-MS) analysis of patient’s breath in an attempt to identify patients with VAP. Breath samples were taken at the same time as the bronchoalveolar lavage samples described above. The use of this technique did show differences between the breath…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.